Processa Pharmaceuticals, Inc. · NASDAQ:PCSA

Skibsted Russell bought 2,292 Processa Pharmaceuticals, Inc. shares (Form 4)

Traded May 29, 2026 · Filed Jun 1, 2026

On May 29, 2026, Skibsted Russell (Chief Financial Officer) bought 2,292 Processa Pharmaceuticals, Inc. shares at US$2.57 for US$5,890, leaving 10,758 shares. Filed Jun 1, 2026 (Form 4).

Bought
2,292 shares
Price
US$2.57
Value
US$5,890
Holding after
10,758 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 29, 2026Common StockBuy2,292US$2.5710,758Direct

Source

View original at SEC

Related